EUVIMEDEUVIMED entdecken
Crossref

Glycated ECM Derived Carbon Dots Inhibit Tumor Vasculogenic Mimicry by Disrupting RAGE Nuclear Translocation and Its Interaction With HMGB1

Shaoting Zheng, Xiaoyan Zhang, Fan Yang, Zhi Chang, Jingxia Han, Heng Zhang, Huijuan Liu, Tao Sun iD

Advanced Materials · 2025

DOI: 10.1002/adma.202419540 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2025. Verfasst von Shaoting Zheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, Tianjin, China. Hauptthemen laut MEDLINE: HMGB1 Protein, Extracellular Matrix, Receptor for Advanced Glycation End Products, Carbon. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigates the role of advanced glycation end‐products (AGEs) in tumor vasculogenic mimicry (VM). Using high‐sugar diet animal models and glycated extracellular matrix (ECM) ex vivo models, AGEs derived is demonstrated from glycated ECM significantly enhanced tumor growth and VM formation. However, carbon dots (egCDs) derived from glycated ECM effectively inhibit tumor growth and VM formation in this glycated microenvironment. Mechanistic studies show that AGEs from glycated ECM bind to the Receptor of Advanced Glycation Endproducts (RAGE) receptors on tumor cells, promoting RAGE nuclear translocation and binding with high mobility group box 1 (HMGB1), which increases the transcription of Snail family transcriptional repressor 2 (SNAI2), thereby driving VM formation. However, egCDs competitively bind to RAGE, promoting its lysosomal degradation and blocking VM formation induced by the RAGE‐HMGB1‐SNAI2 axis. In conclusion, this study demonstrates that egCDs can target RAGE and promote its lysosomal degradation to block VM formation induced by glycated ECM. This finding not only reveals the transformation of glycated ECM from a pro‐VM factor to an anti‐VM therapeutic agent after carbonization, but also provides a theoretical basis for the innovative strategy of “reconstructing pathogenic substances into carbon dots to reverse disease‐driving factors into therapeutic targeting carriers”.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HMGB1 ProteinExtracellular MatrixReceptor for Advanced Glycation End ProductsCarbonNeovascularization, PathologicCell NucleusAnimalsHumansMiceGlycation End Products, AdvancedCell Line, TumorLysosomesGlycosylationProtein Transport

Stichwörter der Autor:innen

AGEs‐RAGE signaling axisCarbon dotsGlycation microenvironmentNuclear translocationTumor vasculogenic mimicry

Substanzen

HMGB1 ProteinReceptor for Advanced Glycation End ProductsCarbonGlycation End Products, Advanced

Autor:innen und Institutionen

  • State Key Laboratory of Medicinal Chemical Biology and College of Pharmacy, Nankai University, Tianjin, China.
  • Tianjin International Joint Academy of Biomedicine, Tianjin, China.

ORCID-Profile: Tao Sun

Förderung

  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Zheng, S., Zhang, X., Yang, F., Chang, Z., Han, J., Zhang, H., Liu, H., & Sun, T. (2025). Glycated ECM Derived Carbon Dots Inhibit Tumor Vasculogenic Mimicry by Disrupting RAGE Nuclear Translocation and Its Interaction With HMGB1. Advanced Materials. https://doi.org/10.1002/adma.202419540

Vancouver

Zheng S, Zhang X, Yang F, Chang Z, Han J, Zhang H, et al. Glycated ECM Derived Carbon Dots Inhibit Tumor Vasculogenic Mimicry by Disrupting RAGE Nuclear Translocation and Its Interaction With HMGB1. Advanced Materials. 2025. doi:10.1002/adma.202419540

BibTeX
@article{Zheng2025,
  author = {Zheng, Shaoting and Zhang, Xiaoyan and Yang, Fan and Chang, Zhi and Han, Jingxia and Zhang, Heng and Liu, Huijuan and Sun, Tao},
  title = {Glycated ECM Derived Carbon Dots Inhibit Tumor Vasculogenic Mimicry by Disrupting RAGE Nuclear Translocation and Its Interaction With HMGB1},
  journal = {Advanced Materials},
  year = {2025},
  doi = {10.1002/adma.202419540}
}
Kostenlos starten →